P. Tarugi and M. Averna, Hypobetalipoproteinemia: genetics, biochemistry, and clinical spectrum, Adv. Clin. Chem, vol.54, pp.81-107, 2011.

A. J. Hooper and J. R. Burnett, Update on primary hypobetalipoproteinemia, Curr. Atheroscler. Rep, vol.16, p.423, 2014.

E. Levy, Insights from human congenital disorders of intestinal lipid metabolism, J. Lipid Res, vol.56, pp.945-962, 2015.

D. Sharp, L. Blinderman, K. A. Combs, B. Kienzle, B. Ricci et al., Cloning and gene defects in microsomal triglyceride transfer protein associated with abetalipoproteinaemia, Nature, vol.365, pp.65-69, 1993.

C. C. Shoulders, D. J. Brett, J. D. Bayliss, T. M. Narcisi, A. Jarmuz et al., Abetalipoproteinemia is caused by defects of the gene encoding the 97 kDa subunit of a microsomal triglyceride transfer protein, Hum. Mol. Genet, vol.2, pp.2109-2116, 1993.

B. Jones, E. L. Jones, S. A. Bonney, H. N. Patel, A. R. Mensenkamp et al., Mutations in a Sar1 GTPase of COPII vesicles are associated with lipid absorption disorders, Nat. Genet, vol.34, pp.29-31, 2003.

M. Di-filippo, P. Moulin, P. Roy, M. E. Samson-bouma, S. Collardeau-frachon et al., Homozygous MTTP and APOB mutations may lead to hepatic steatosis and fibrosis despite metabolic differences in congenital hypocholesterolemia, J. Hepatol, vol.61, pp.891-902, 2014.
URL : https://hal.archives-ouvertes.fr/hal-01859387

R. Zamel, R. Khan, R. L. Pollex, and R. A. Hegele, Abetalipoproteinemia: two case reports and literature review, Orphanet J. Rare Dis, vol.3, p.19, 2008.

D. P. Muller, J. K. Lloyd, and A. C. Bird, Long-term management of abetalipoproteinaemia. Possible role for vitamin E, Arch. Dis. Child, vol.52, pp.209-214, 1977.

D. P. Muller and J. K. Lloyd, Effect of large oral doses of vitamin E on the neurological sequelae of patients with abetalipoproteinemia, Ann. N. Y. Acad. Sci, vol.393, pp.133-144, 1982.

P. Runge, D. P. Muller, J. Mcallister, D. Calver, J. K. Lloyd et al., Oral vitamin E supplements can prevent the retinopathy of abetalipoproteinaemia, Br. J. Ophthalmol, vol.70, pp.166-173, 1986.

I. Chowers, E. Banin, S. Merin, M. Cooper, and E. Granot, Long-term assessment of combined vitamin A and E treatment for the prevention of retinal degeneration in abetalipoproteinaemia and hypobetalipoproteinaemia patients, Eye (Lond.), vol.15, pp.525-530, 2001.

R. J. Sokol, N. Butler-simon, C. Conner, J. E. Heubi, F. R. Sinatra et al., Multicenter trial of d-alpha-tocopheryl polyethylene glycol 1000 succinate for treatment of vitamin E deficiency in children with chronic cholestasis, Gastroenterology, vol.104, pp.1727-1735, 1993.

K. Papas, J. Kalbfleisch, and R. Mohon, Bioavailability of a novel, water-soluble vitamin E formulation in malabsorbing patients, Dig. Dis. Sci, vol.52, pp.347-352, 2007.

E. Jacquemin, B. Hermeziu, Y. Kibleur, I. Friteau, D. Mathieu et al., Bioavailability of oral vitamin E formulations in adult volunteers and children with chronic cholestasis or cystic fibrosis, J. Clin. Pharm. Ther, vol.34, pp.515-522, 2009.

H. J. Kayden, L. J. Hatam, and M. G. Traber, The measurement of nanograms of tocopherol from needle aspiration biopsies of adipose tissue: normal and abetalipoproteinemic subjects, J. Lipid Res, vol.24, pp.652-656, 1983.

J. G. Bieri and R. K. Poukka, Red cell content of vitamin E and fatty acids in normal subjects and patients with abnormal lipid metabolism, Int. Z. Vitaminforsch, vol.40, pp.344-350, 1970.

L. J. Hatam and H. J. Kayden, A high-performance liquid chromatographic method for the determination of tocopherol in plasma and cellular elements of the blood, J. Lipid Res, vol.20, pp.639-645, 1979.

C. Cuerq, L. Restier, J. Drai, E. Blond, A. Roux et al., Establishment of reference values of alpha-tocopherol in plasma, red blood cells and adipose tissue in healthy children to improve the management of chylomicron retention disease, a rare genetic hypocholesterolemia, Orphanet J. Rare Dis, vol.11, p.114, 2016.
URL : https://hal.archives-ouvertes.fr/hal-01850299

L. Chardon, A. Sassolas, B. Dingeon, L. Michel-calemard, M. Bovier-lapierre et al., Identification of two novel mutations and long-term follow-up in abetalipoproteinemia: a report of four cases, Eur. J. Pediatr, vol.168, pp.983-989, 2009.

M. Charcosset, A. Sassolas, N. Peretti, C. C. Roy, C. Deslandres et al., Anderson or chylomicron retention disease: molecular impact of five mutations in the SAR1B gene on the structure and the functionality of Sar1b protein, Mol. Genet. Metab, vol.93, pp.74-84, 2008.

D. P. Muller, J. K. Lloyd, and O. H. Wolff, The role of vitamin E in the treatment of the neurological features of abetalipoproteinaemia and other disorders of fat absorption, J. Inherit. Metab. Dis, vol.8, issue.1, pp.88-92, 1985.

N. Peretti, A. Sassolas, C. C. Roy, C. Deslandres, M. Charcosset et al., Guidelines for the diagnosis and management of chylomicron retention disease based on a review of the literature and the experience of two centers, Orphanet J. Rare Dis, vol.5, p.24, 2010.
URL : https://hal.archives-ouvertes.fr/inserm-00654377

C. Cuerq, N. Peretti, K. Chikh, A. Mialon, M. Guillaumont et al., Overview of the in vitro stability of commonly measured vitamins and carotenoids in whole blood, Ann. Clin. Biochem, vol.52, pp.259-269, 2015.
URL : https://hal.archives-ouvertes.fr/hal-01601143

J. P. Steghens, A. L. Van-kappel, E. Riboli, and C. Collombel, Simultaneous measurement of seven carotenoids, retinol and alphatocopherol in serum by high-performance liquid chromatography, J. Chromatogr. B Biomed. Sci. Appl, vol.694, pp.71-81, 1997.

J. G. Bieri, T. J. Tolliver, and G. L. Catignani, Simultaneous determination of alpha-tocopherol and retinol in plasma or red cells by high pressure liquid chromatography, Am. J. Clin. Nutr, vol.32, pp.2143-2149, 1979.

T. Liu, P. Ghafoori, and J. V. Gobburu, Allometry is a reasonable choice in pediatric drug development, J. Clin. Pharmacol, vol.57, pp.469-475, 2017.

N. Holford, Y. A. Heo, and B. Anderson, A pharmacokinetic standard for babies and adults, J. Pharm. Sci, vol.102, pp.2941-2952, 2013.

S. Beal, L. Sheiner, A. Boeckmann, and R. Bauer, NONMEM User's Guides, 1989.

M. Silvain, D. Bligny, T. Aparicio, P. Laforet, A. Grodet et al., Anderson's disease (chylomicron retention disease): a new mutation in the SARA2 gene associated with muscular and cardiac abnormalities, Clin. Genet, vol.74, pp.546-552, 2008.

M. G. Traber, D. Rader, R. V. Acuff, H. B. Brewer, and H. J. Kayden, Discrimination between RRR-and all-racemic-alpha-tocopherols labeled with deuterium by patients with abetalipoproteinemia, Atherosclerosis, vol.108, pp.27-37, 1994.

N. V. Dimitrov, C. Meyer-leece, J. Mcmillan, D. Gilliland, M. Perloff et al., Plasma alpha-tocopherol concentrations after supplementation with water-and fat-soluble vitamin E, Am. J. Clin. Nutr, vol.64, pp.329-335, 1996.

M. G. Traber, R. J. Sokol, S. P. Ringel, H. E. Neville, C. A. Thellman et al., Lack of tocopherol in peripheral nerves of vitamin E-deficient patients with peripheral neuropathy, N. Engl. J. Med, vol.317, pp.262-265, 1987.

P. Socha, B. Koletzko, J. Pawlowska, K. Proszynska, and J. Socha, Treatment of cholestatic children with water-soluble vitamin E (alpha-tocopheryl polyethylene glycol succinate): effects on serum vitamin E, lipid peroxides, and polyunsaturated fatty acids, J. Pediatr. Gastroenterol. Nutr, vol.24, pp.189-193, 1997.

D. K. Melhorn, Vitamin E: who needs it? II. Diseases associated with vitamin E deficiency, Ohio State Med. J, vol.69, pp.830-833, 1973.

M. G. Traber, T. D. Schiano, A. C. Steephen, H. J. Kayden, and M. Shike, Efficacy of water-soluble vitamin E in the treatment of vitamin E malabsorption in short-bowel syndrome, Am. J. Clin. Nutr, vol.59, pp.1270-1274, 1994.

C. Calzada, E. Vericel, R. Colas, N. Guillot, G. E. Khoury et al., Inhibitory effects of in vivo oxidized high-density lipoproteins on platelet aggregation: evidence from patients with abetalipoproteinemia, FASEB J, vol.27, pp.2855-2861, 2013.
URL : https://hal.archives-ouvertes.fr/hal-01889290

A. Sassolas, M. D. Filippo, L. P. Aggerbeck, N. Peretti, and M. E. Samson-bouma, Anderson's disease/chylomicron retention disease and mutations in the SAR1B gene, Mutations in, pp.251-272, 2012.

N. Berriot-varoqueaux, A. H. Dannoura, A. Moreau, N. Verthier, A. Sassolas et al., Apolipoprotein B48 glycosylation in abetalipoproteinemia and Anderson's disease, Gastroenterology, vol.121, pp.1101-1108, 2001.

M. E. Bouma, I. Beucler, L. P. Aggerbeck, R. Infante, and J. Schmitz, Hypobetalipoproteinemia with accumulation of an apoprotein B-like protein in intestinal cells. Immunoenzymatic and biochemical characterization of seven cases of Anderson's disease, J. Clin. Invest, vol.78, pp.398-410, 1986.

C. C. Roy, E. Levy, P. H. Green, A. Sniderman, J. Letarte et al., Malabsorption, hypocholesterolemia, and fat-filled enterocytes with increased intestinal apoprotein B. Chylomicron retention disease, Gastroenterology, vol.92, pp.390-399, 1987.

A. Georges, J. Bonneau, D. Bonnefont-rousselot, J. Champigneulle, J. P. Rabes et al., Molecular analysis and intestinal expression of SAR1 genes and proteins in Anderson's disease (Chylomicron retention disease), Orphanet J. Rare Dis, vol.6, p.1, 2011.

S. Restellini, M. Alaei, T. Matthes, O. Kherad, A. Moschetta et al., Effect of hydrosoluble vitamin E on erythrocyte membrane lipid composition in patients with advanced cirrhosis: an open-label pilot trial, Hepatol. Res, vol.45, pp.890-897, 2015.